Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 41 studies | 48% ± 21% | |
smooth muscle cell | 31 studies | 45% ± 18% | |
pericyte | 26 studies | 35% ± 15% | |
endothelial cell of lymphatic vessel | 18 studies | 31% ± 12% | |
endothelial cell | 15 studies | 24% ± 11% | |
myofibroblast cell | 15 studies | 61% ± 21% | |
connective tissue cell | 14 studies | 49% ± 19% | |
mesothelial cell | 10 studies | 34% ± 19% | |
adipocyte | 10 studies | 46% ± 15% | |
platelet | 8 studies | 31% ± 9% | |
capillary endothelial cell | 8 studies | 26% ± 8% | |
GABAergic neuron | 7 studies | 35% ± 20% | |
glutamatergic neuron | 7 studies | 42% ± 29% | |
neuron | 6 studies | 28% ± 16% | |
oligodendrocyte precursor cell | 6 studies | 32% ± 12% | |
astrocyte | 5 studies | 29% ± 10% | |
adventitial cell | 5 studies | 45% ± 24% | |
alveolar macrophage | 5 studies | 26% ± 5% | |
cardiac muscle cell | 5 studies | 44% ± 6% | |
endothelial cell of vascular tree | 5 studies | 20% ± 6% | |
interneuron | 5 studies | 34% ± 19% | |
hematopoietic stem cell | 5 studies | 34% ± 10% | |
retina horizontal cell | 4 studies | 34% ± 11% | |
Mueller cell | 4 studies | 38% ± 13% | |
muscle cell | 4 studies | 53% ± 22% | |
abnormal cell | 3 studies | 29% ± 13% | |
amacrine cell | 3 studies | 40% ± 14% | |
endothelial cell of artery | 3 studies | 20% ± 3% | |
type I pneumocyte | 3 studies | 30% ± 14% | |
mast cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 71% | 34173.39 | 173 / 245 | 87% | 92.13 | 438 / 502 |
thymus | 78% | 23254.73 | 510 / 653 | 76% | 113.34 | 458 / 605 |
brain | 25% | 4765.73 | 669 / 2642 | 99% | 257.80 | 701 / 705 |
uterus | 91% | 43983.48 | 154 / 170 | 28% | 45.57 | 129 / 459 |
lung | 89% | 31456.50 | 513 / 578 | 26% | 20.26 | 298 / 1155 |
breast | 81% | 46057.86 | 372 / 459 | 32% | 17.99 | 362 / 1118 |
bladder | 86% | 54323.95 | 18 / 21 | 20% | 15.27 | 103 / 504 |
esophagus | 70% | 76291.17 | 1007 / 1445 | 33% | 20.48 | 60 / 183 |
muscle | 100% | 380543.28 | 803 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 126759.35 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 72059.43 | 1186 / 1204 | 0% | 0 | 0 / 0 |
intestine | 78% | 49652.97 | 757 / 966 | 19% | 11.65 | 100 / 527 |
kidney | 2% | 347.38 | 2 / 89 | 85% | 277.99 | 766 / 901 |
heart | 87% | 60885.97 | 747 / 861 | 0% | 0 | 0 / 0 |
stomach | 48% | 34424.76 | 171 / 359 | 30% | 35.04 | 86 / 286 |
adrenal gland | 0% | 85.89 | 1 / 258 | 67% | 45.30 | 153 / 230 |
ovary | 15% | 4853.43 | 27 / 180 | 33% | 16.98 | 144 / 430 |
pancreas | 0% | 0 | 0 / 328 | 38% | 21.88 | 68 / 178 |
skin | 15% | 3275.88 | 274 / 1809 | 22% | 9.47 | 104 / 472 |
eye | 0% | 0 | 0 / 0 | 28% | 8.41 | 22 / 80 |
tonsil | 0% | 0 | 0 / 0 | 24% | 15.32 | 11 / 45 |
liver | 0% | 0 | 0 / 226 | 8% | 2.91 | 31 / 406 |
spleen | 1% | 141.54 | 2 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 69.05 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0010972 | Biological process | negative regulation of G2/M transition of mitotic cell cycle |
GO_0043268 | Biological process | positive regulation of potassium ion transport |
GO_1901016 | Biological process | regulation of potassium ion transmembrane transporter activity |
GO_0030154 | Biological process | cell differentiation |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0007517 | Biological process | muscle organ development |
GO_0003254 | Biological process | regulation of membrane depolarization |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005829 | Cellular component | cytosol |
GO_0005925 | Cellular component | focal adhesion |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
GO_0046872 | Molecular function | metal ion binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
Gene name | FHL1 |
Protein name | Four and a half LIM domains 1 Four and a half LIM domains protein 1 (FHL-1) (Skeletal muscle LIM-protein 1) (SLIM) (SLIM-1) |
Synonyms | SLIM1 |
Description | FUNCTION: May have an involvement in muscle development or hypertrophy. |
Accessions | A0A0D9SEY7 A0A0D9SFB0 ENST00000651929.2 [Q13642-1] ENST00000394155.8 [Q13642-2] Q5JXH8 ENST00000370676.7 ENST00000452016.5 ENST00000628919.3 [Q13642-1] ENST00000627578.2 Q13642 ENST00000434885.5 A0A494C1G1 Q5JXH7 Q5JXI0 ENST00000625935.2 ENST00000628443.2 ENST00000535737.5 [Q13642-1] ENST00000543669.5 [Q13642-1] ENST00000370674.3 ENST00000652745.1 ENST00000627383.2 ENST00000627812.2 A0A494C0J3 ENST00000449474.5 ENST00000630278.2 Q5JXI3 A0A0D9SGD1 ENST00000458357.5 Q5JXI8 A0A0D9SFZ9 ENST00000652457.1 ENST00000539015.5 [Q13642-4] ENST00000456445.5 Q5JXH9 ENST00000420362.5 A0A0D9SGC5 ENST00000630084.2 [Q13642-1] ENST00000628032.2 ENST00000618438.4 [Q13642-3] A0A0D9SFI6 Q5JXI2 ENST00000629039.2 [Q13642-1] A0A0D9SGB2 ENST00000651256.1 A0A494C0D6 ENST00000628568.1 [Q13642-1] ENST00000370683.6 [Q13642-5] ENST00000394153.6 [Q13642-1] ENST00000651089.1 [Q13642-2] |